Skip to main content
Top
Published in: European Radiology 7/2014

01-07-2014 | Breast

Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy

Authors: Meroni Stefano, Bozzini Anna Carla, Pruneri Giancarlo, Moscovici Oana Codrina, Maisonneuve Patrick, Menna Simona, Penco Silvia, Meneghetti Lorenza, Renne Giuseppe, Cassano Enrico

Published in: European Radiology | Issue 7/2014

Login to get access

Abstract

Objectives

To evaluate the underestimation rate and clinical relevance of lobular neoplasia in vacuum-assisted breast biopsy (VABB).

Methods

A total of 161 cases of LN were retrieved from 6,435 VABB. The histological diagnosis was ALH (atypical lobular hyperplasia) in 80 patients, LCIS (lobular carcinoma in situ) in 69 patients and PLCIS (pleomorphic lobular carcinoma in situ) in 12 patients. Seventy-six patients were operated on within 2 years after VABB and 85 were clinically and radiologically monitored. The mean follow-up was 5.2 years, and the prevalence of malignancy was evaluated in the group of 85 patients.

Results

The clinico-pathological characteristics significantly favouring surgery were larger lesions, occurrence of a residual lesion following VABB and histological LCIS and PLCIS subtypes. The VABB underestimation rate as compared to surgery was 7.1 % for ALH, 12 % for LCIS and 50 % for PLCIS. Overall, 11 of the 148 patients included in this survival analysis developed an ipsilateral tumour.

Conclusion

Although obtained retrospectively in a relatively small series of patients, our data suggest that only patients with a diagnosis of PLCIS in VABB should be treated with surgery, whereas patients with ALH and LCIS could be monitored by clinical and radiological examinations.

Key Points

The treatment of ALH and LCIS in VABB is still debated
Some authors favour radical treatment and others a more conservative approach
Only patients with PLCIS in VABB should be treated by surgery
Literature
1.
2.
go back to reference Haagensen CD, Lane N, Lattes R et al (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737–769PubMedCrossRef Haagensen CD, Lane N, Lattes R et al (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737–769PubMedCrossRef
3.
go back to reference Hussain M, Cunnick GH (2011) Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast. A review. EJSO 37:279–289PubMedCrossRef Hussain M, Cunnick GH (2011) Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast. A review. EJSO 37:279–289PubMedCrossRef
4.
5.
go back to reference Simpson PT, Reis-Filho JS, Lambros MB et al (2008) Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 215:231–244PubMedCrossRef Simpson PT, Reis-Filho JS, Lambros MB et al (2008) Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 215:231–244PubMedCrossRef
6.
go back to reference Carder PJ, Shaaban AM, Alizadeh Y et al (2010) Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis. Histopathology 57:472–478PubMedCrossRef Carder PJ, Shaaban AM, Alizadeh Y et al (2010) Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis. Histopathology 57:472–478PubMedCrossRef
7.
go back to reference Chen YY, Hwang ES, Roy R et al (2009) Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol 33:1683–1694PubMedCentralPubMedCrossRef Chen YY, Hwang ES, Roy R et al (2009) Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol 33:1683–1694PubMedCentralPubMedCrossRef
8.
go back to reference Masannat YA, Bains SK, Pinder SE et al (2013) Challenges in the management of pleomorphic lobular carcinoma in situ of the breast. Breast 22:194–196PubMedCrossRef Masannat YA, Bains SK, Pinder SE et al (2013) Challenges in the management of pleomorphic lobular carcinoma in situ of the breast. Breast 22:194–196PubMedCrossRef
9.
go back to reference Lakhani S (2012) WHO classification of tumours of the breast, 4th edn. International Agency for Research on Cancer, Lyon Lakhani S (2012) WHO classification of tumours of the breast, 4th edn. International Agency for Research on Cancer, Lyon
10.
go back to reference Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440:134–138PubMedCrossRef Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440:134–138PubMedCrossRef
11.
go back to reference Chuba PJ, Hamre MR, Yap J et al (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23:5534–5541PubMedCrossRef Chuba PJ, Hamre MR, Yap J et al (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23:5534–5541PubMedCrossRef
12.
go back to reference O’Malley FP (2010) Lobular neoplasia: morphology, biological potential and management in core biopsies. Mod Pathol 23:S14–S25PubMedCrossRef O’Malley FP (2010) Lobular neoplasia: morphology, biological potential and management in core biopsies. Mod Pathol 23:S14–S25PubMedCrossRef
13.
go back to reference Provencher L, Jacob S, Côté G et al (2012) Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy. Radiology 263:43–52PubMedCrossRef Provencher L, Jacob S, Côté G et al (2012) Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy. Radiology 263:43–52PubMedCrossRef
14.
go back to reference Wheeler JE, Enterline HT, Roseman JM et al (1974) Lobular carcinoma in situ of the breast. Long-term followup. Cancer 34:554–563PubMedCrossRef Wheeler JE, Enterline HT, Roseman JM et al (1974) Lobular carcinoma in situ of the breast. Long-term followup. Cancer 34:554–563PubMedCrossRef
15.
go back to reference Page DL, Kidd TE Jr, Dupont WD et al (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232–1239PubMedCrossRef Page DL, Kidd TE Jr, Dupont WD et al (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232–1239PubMedCrossRef
16.
go back to reference Shah-Khan MG, Geiger XJ, Reynolds C et al (2012) Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol 19:3131–3138PubMedCrossRef Shah-Khan MG, Geiger XJ, Reynolds C et al (2012) Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol 19:3131–3138PubMedCrossRef
17.
go back to reference Dmytrasz K, Tartter PI, Mizrachy H et al (2003) The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J 9:10–12PubMedCrossRef Dmytrasz K, Tartter PI, Mizrachy H et al (2003) The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J 9:10–12PubMedCrossRef
18.
go back to reference Georgian-Smith D, Lawton TJ (2012) Variations in physician recommendations for surgery after diagnosis of a high-risk lesion on breast core needle biopsy. AJR 198:256–263PubMedCrossRef Georgian-Smith D, Lawton TJ (2012) Variations in physician recommendations for surgery after diagnosis of a high-risk lesion on breast core needle biopsy. AJR 198:256–263PubMedCrossRef
19.
go back to reference Cutuli B, de Lafontan B, Quetin P et al (2005) Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ? Eur J Cancer 41:380–385PubMedCrossRef Cutuli B, de Lafontan B, Quetin P et al (2005) Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ? Eur J Cancer 41:380–385PubMedCrossRef
20.
go back to reference Niell B, Specht M, Gerade B et al (2012) Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? AJR 199:929–935PubMedCrossRef Niell B, Specht M, Gerade B et al (2012) Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? AJR 199:929–935PubMedCrossRef
21.
go back to reference Cohen MA (2004) Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology 231:617–621PubMedCrossRef Cohen MA (2004) Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology 231:617–621PubMedCrossRef
22.
go back to reference Linda A, Zuiani C, Furlan A et al (2012) Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR 198:272–280PubMedCrossRef Linda A, Zuiani C, Furlan A et al (2012) Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR 198:272–280PubMedCrossRef
23.
go back to reference Friedlander LC, Roth SO, Gavenonis SC (2011) Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology 261:421–427PubMedCrossRef Friedlander LC, Roth SO, Gavenonis SC (2011) Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology 261:421–427PubMedCrossRef
24.
go back to reference Sung JS, Malak SF, Bajaj P et al (2011) Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 261:414–420PubMedCrossRef Sung JS, Malak SF, Bajaj P et al (2011) Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 261:414–420PubMedCrossRef
25.
go back to reference Sohn VY, Arthurs ZM, Kim FS et al (2008) Lobular neoplasia: is surgical excision warranted? Am Surg 74:172–177PubMed Sohn VY, Arthurs ZM, Kim FS et al (2008) Lobular neoplasia: is surgical excision warranted? Am Surg 74:172–177PubMed
26.
go back to reference Renshaw AA, Cartagena N, Derhagopian RP et al (2002) Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 117:797–799PubMedCrossRef Renshaw AA, Cartagena N, Derhagopian RP et al (2002) Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 117:797–799PubMedCrossRef
27.
go back to reference Nagi CS, O'Donnell JE, Tismenetsky M et al (2008) Lobular neoplasia on core needle biopsy does not require excision. Cancer 112:2152–2158PubMedCrossRef Nagi CS, O'Donnell JE, Tismenetsky M et al (2008) Lobular neoplasia on core needle biopsy does not require excision. Cancer 112:2152–2158PubMedCrossRef
28.
go back to reference Fischer B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast & bowel project P-1 study. J Natl Cancer Inst 90:1371–1388CrossRef Fischer B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast & bowel project P-1 study. J Natl Cancer Inst 90:1371–1388CrossRef
29.
go back to reference European Commission (2005) European guidelines for quality assurance in mammography screening, 3rd edn. EC, Luxembourg European Commission (2005) European guidelines for quality assurance in mammography screening, 3rd edn. EC, Luxembourg
30.
go back to reference Rosen PP, Kosloff C, Lieberman PH et al (1978) Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2:225–251PubMedCrossRef Rosen PP, Kosloff C, Lieberman PH et al (1978) Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2:225–251PubMedCrossRef
31.
go back to reference London SJ, Connoly JL, Schmitt SJ et al (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941–944PubMedCrossRef London SJ, Connoly JL, Schmitt SJ et al (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941–944PubMedCrossRef
32.
go back to reference Hartmann LC, Sellers TA, Frost MH et al (2005) Benign breast disease and the risk of breast cancer. NEJM 353:229–237PubMedCrossRef Hartmann LC, Sellers TA, Frost MH et al (2005) Benign breast disease and the risk of breast cancer. NEJM 353:229–237PubMedCrossRef
33.
go back to reference Elsheikh TM, Silverman JF (2005) Follow up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 29:534–543PubMedCrossRef Elsheikh TM, Silverman JF (2005) Follow up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 29:534–543PubMedCrossRef
34.
go back to reference Mahoney MC, Robinson-Smith TM, Shaughnessy EA (2006) Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR 187:949–954PubMedCrossRef Mahoney MC, Robinson-Smith TM, Shaughnessy EA (2006) Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR 187:949–954PubMedCrossRef
35.
go back to reference Brem RF, Lechner MC, Jackman RJ et al (2008) Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR 190:637–641PubMedCrossRef Brem RF, Lechner MC, Jackman RJ et al (2008) Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR 190:637–641PubMedCrossRef
36.
go back to reference Hwang H, Barke LD, Mendelson EB et al (2008) Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol 21:1208–1216PubMedCrossRef Hwang H, Barke LD, Mendelson EB et al (2008) Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol 21:1208–1216PubMedCrossRef
37.
go back to reference Destounis SV, Murphy PF, Seifert PJ et al (2012) Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. AJR 198:281–287PubMedCrossRef Destounis SV, Murphy PF, Seifert PJ et al (2012) Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. AJR 198:281–287PubMedCrossRef
Metadata
Title
Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy
Authors
Meroni Stefano
Bozzini Anna Carla
Pruneri Giancarlo
Moscovici Oana Codrina
Maisonneuve Patrick
Menna Simona
Penco Silvia
Meneghetti Lorenza
Renne Giuseppe
Cassano Enrico
Publication date
01-07-2014
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 7/2014
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3132-y

Other articles of this Issue 7/2014

European Radiology 7/2014 Go to the issue